4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol has been researched along with 2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide in 1 studies
| Studies (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Trials (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Recent Studies (post-2010) (4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol) | Studies (2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide) | Trials (2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide) | Recent Studies (post-2010) (2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide) |
|---|---|---|---|---|---|
| 70 | 12 | 9 | 6 | 0 | 0 |
| Protein | Taxonomy | 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol (IC50) | 2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide (IC50) |
|---|---|---|---|
| tumor necrosis factor | Homo sapiens (human) | 4.549 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abagyan, R; Cottam, HB; Kaler, G; Saldanha, SA; Taylor, SS | 1 |
1 other study(ies) available for 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol and 2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide
| Article | Year |
|---|---|
Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Binding, Competitive; Biological Assay; Cyclic AMP-Dependent Protein Kinases; Fluorescence Polarization; Ligands; Molecular Sequence Data; Protein Binding; Substrate Specificity | 2006 |